dalteparin has been researched along with Psoriasis in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, HW | 1 |
| Tan, C | 1 |
1 other study available for dalteparin and Psoriasis
| Article | Year |
|---|---|
Acute Generalized Pustular Bacterid: An Uncommon Dermatosis That Commonly Presents With Acral Pustules.
Topics: Acute Generalized Exanthematous Pustulosis; Heparin, Low-Molecular-Weight; Humans; Psoriasis; Skin D | 2019 |